Abstract:OBJECTIVE:To study the outcomes of nerve defect repair with the tissue engineered nerve, which is composed of the complex of SCs, 30% ECM gel, bFGF-PLGA sustained release microspheres, PLGA microfilaments and permeable poly (D, L-lactic acid) (PDLLA) catheters.METHODS:SCs were cultured and purified from the sciatic nerves of 1-day-old neonatal SD rats. The 1st passage cells were compounded with bFGF-PLGA sustained release microspheres and ECM gel, and then were injected into permeable PDLLA catheters with PLGA microfilaments inside. In this way, the tissue engineered nerve was constructed. Sixty SD rats were included. The model of 15-mm sciatic nerve defects was made, and then the rats were randomly divided into 5 groups, with 12 rats in each. In group A, autograft was adopted. In group B, the blank PDLLA catheters with PBS inside were used. In group C, PDLLA catheters, with PLGA microfilaments and 30% ECM gel inside, were used. In group D, PDLLA catheters, with PLGA microfilaments, SCs and 30% ECM gel inside, were used. In group E, the tissue engineered nerve was applied. After the operation, observation was made for general conditions of the rats. The sciatic function index (SFI) analysis was performed at 12, 16, 20 and 24 weeks after the operation, respectively. Electrophysiological detection and histological observation were performed at 12 and 24 weeks after the operation, respectively.RESULTS:All rats survived to the end of the experiment. At 12 and 16 weeks after the operation, group E was significantly different from group B in SFI (P < 0.05). At 20 and 24 weeks after the operation, group E was significantly different from groups B and C in SFI (P < 0.05). At 12 weeks after the operation, electrophysiological detection showed nerve conduct velocity (NCV) of group E was bigger than that of groups B and C (P < 0.05), and compound amplitude (AMP) as well as action potential area (AREA) of group E were bigger than those of groups B, C and D (P < 0.05). At 24 weeks after the operation, NCV, AMP and AREA of group E were bigger than those of groups B and C (P < 0.05). At 12 weeks after the operation, histological observation showed the area of regenerated nerves and the number of myelinated fibers in group E were significantly differents from those in groups A, B and C (P < 0.05). The density and diameter of myelinated fibers in group E were smaller than those in group A (P < 0.05), but bigger than those in groups B, C and D (P < 0.05). At 24 weeks after the operation, the area of regenerative nerves in group E is bigger than those in group B (P < 0.05); the number of myelinated fibers in group E was significantly different from those in groups A, B, C (P < 0.05); and the density and diameter of myelinated fibers in group E were bigger than those in groups B and C (P < 0.05).CONCLUSION:The tissue engineered nerve with the complex of SCs, ECM gel, bFGF-PLGA sustained release microspheres, PLGA microfilaments and permeable PDLLA catheters promote nerve regeneration and has similar effect to autograft in repair of nerve defects.

Repair of Rat Sciatic Nerve Gap by a Silk Fibroin-Based Scaffold Added with Bone Marrow Mesenchymal Stem Cells.

Repair of Rat Sciatic Nerve Defects by Using Allogeneic Bone Marrow Mononuclear Cells Combined with Chitosan/Silk Fibroin Scaffold

Bridging Peripheral Nerve Defects with a Tissue Engineered Nerve Graft Composed of an in Vitro Cultured Nerve Equivalent and a Silk Fibroin-Based Scaffold

A Silk Fibroin/Collagen Nerve Scaffold Seeded with a Co-Culture of Schwann Cells and Adipose-Derived Stem Cells for Sciatic Nerve Regeneration

Tissue-Engineered Regeneration of Completely Transected Spinal Cord Using Induced Neural Stem Cells and Gelatin-Electrospun Poly (Lactide-Co-Glycolide)/Polyethylene Glycol Scaffolds

Use of Tissue-Engineered Nerve Grafts Consisting of a Chitosan/Poly(lactic-co-glycolic Acid)-Based Scaffold Included with Bone Marrow Mesenchymal Cells for Bridging 50-Mm Dog Sciatic Nerve Gaps

Long-term Outcome of the Repair of 50 Mm Long Median Nerve Defects in Rhesus Monkeys with Marrow Mesenchymal Stem Cells-Containing, Chitosan-Based Tissue Engineered Nerve Grafts

Joint Use of a Chitosan/PLGA Scaffold and MSCs to Bridge an Extra Large Gap in Dog Sciatic Nerve

Chitosan/silk Fibroin-Based Tissue-Engineered Graft Seeded with Adipose-Derived Stem Cells Enhances Nerve Regeneration in a Rat Model

Bone Marrow Mesenchymal Stem Cell-Derived Acellular Matrix-Coated Chitosan/Silk Scaffolds for Neural Tissue Regeneration

PNGF conduit seeded with bone marrow derived mesenchymal stem cells to repair 12-mm sciatic nerve defect of rat

The delayed repair of sciatic nerve defects with tissue-engineered nerve grafts in rats.

Hybrid construction of tissue-engineered nerve graft using skin derived precursors induced neurons and Schwann cells to enhance peripheral neuroregeneration

Improvement of Peripheral Nerve Regeneration by a Tissue-Engineered Nerve Filled with Ectomesenchymal Stem Cells

Chitosan/silk Fibroin-Based, Schwann Cell-Derived Extracellular Matrix-Modified Scaffolds for Bridging Rat Sciatic Nerve Gaps

Tissue-engineered nerve grafts using a scaffold-independent and injectable drug delivery system: a novel design with translational advantages

Development and biocompatibility evaluation of silk fibroin-based nerve grafts for peripheral nerve regeneration

Brachial Plexus Bridging with Specific Extracellular Matrix-Modified Chitosan/silk Scaffold: a New Expand of Tissue Engineered Nerve Graft

Effective regeneration of rat sciatic nerve using nanofibrous scaffolds containing rat ADSCs with controlled release of rhNGF and melatonin molecules for the treatment of peripheral injury model

Silk-inspired fiber implant with multi-cues enhanced bionic microenvironment for promoting peripheral nerve repair

[Construction and Evaluation of the Tissue Engineered Nerve of Bfgf-Plga Sustained Release Microspheres].